Correlation Between China SXT and Harrow Health,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China SXT and Harrow Health, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China SXT and Harrow Health, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China SXT Pharmaceuticals and Harrow Health, 11875, you can compare the effects of market volatilities on China SXT and Harrow Health, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China SXT with a short position of Harrow Health,. Check out your portfolio center. Please also check ongoing floating volatility patterns of China SXT and Harrow Health,.

Diversification Opportunities for China SXT and Harrow Health,

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between China and Harrow is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding China SXT Pharmaceuticals and Harrow Health, 11875 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Harrow Health, 11875 and China SXT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China SXT Pharmaceuticals are associated (or correlated) with Harrow Health,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Harrow Health, 11875 has no effect on the direction of China SXT i.e., China SXT and Harrow Health, go up and down completely randomly.

Pair Corralation between China SXT and Harrow Health,

Given the investment horizon of 90 days China SXT Pharmaceuticals is expected to under-perform the Harrow Health,. In addition to that, China SXT is 10.83 times more volatile than Harrow Health, 11875. It trades about -0.4 of its total potential returns per unit of risk. Harrow Health, 11875 is currently generating about -0.02 per unit of volatility. If you would invest  2,640  in Harrow Health, 11875 on August 24, 2024 and sell it today you would lose (5.00) from holding Harrow Health, 11875 or give up 0.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

China SXT Pharmaceuticals  vs.  Harrow Health, 11875

 Performance 
       Timeline  
China SXT Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China SXT Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Harrow Health, 11875 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Harrow Health, 11875 are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Harrow Health, is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

China SXT and Harrow Health, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China SXT and Harrow Health,

The main advantage of trading using opposite China SXT and Harrow Health, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China SXT position performs unexpectedly, Harrow Health, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harrow Health, will offset losses from the drop in Harrow Health,'s long position.
The idea behind China SXT Pharmaceuticals and Harrow Health, 11875 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios